SpectRx, Inc. Schedules Date for Release of Third Quarter 2004 Results
11 Noviembre 2004 - 6:45AM
PR Newswire (US)
SpectRx, Inc. Schedules Date for Release of Third Quarter 2004
Results NORCROSS, Ga., Nov. 4 /PRNewswire-FirstCall/ -- SpectRx,
Inc. (OTC:SPRX) (BULLETIN BOARD: SPRX) announced today that it
plans to release third quarter 2004 results after the market closes
on Wednesday, November 10, 2004. SpectRx will host a conference
call and webcast to review the Company's financial results on
Thursday, November 11, 2004 at 11:30 a.m. Eastern Time. The webcast
will be made available at http://www.fulldisclosure.com/ or
http://www.ccbn.com/ . The telephone number to participate in the
conference call is 800-889-0817. A replay of the conference call
will be made available until November 17, 2004, by dialing
800-642-1687, passcode 2051502. About SpectRx SpectRx, Inc.
(OTC:SPRX) (BULLETIN BOARD: SPRX) is a diabetes management company
developing and providing innovative solutions for insulin delivery
and glucose monitoring. SpectRx markets the SimpleChoice(R) line of
innovative diabetes management products, which include insulin pump
disposable supplies. SpectRx also plans to develop a consumer
device for continuous glucose monitoring. The company is
commercializing its non-invasive cancer detection technology
through subsidiary company Guided Therapeutics, Inc, which SpectRx
intends to separately finance with private funds. For more
information, visit SpectRx's web sites at spectrx.com,
mysimplechoice.com and guidedtherapeutics.com . DATASOURCE:
SpectRx, Inc. CONTACT: Media, Bill Wells, or Financial, Thomas H.
Muller, Jr., of SpectRx, Inc., +1-770-242-8723 Web site:
http://www.spectrx.com/ http://www.mysimplechoice.com/
http://www.guidedtherapeutics.com/ http://www.fulldisclosure.com/
http://www.ccbn.com/
Copyright